Redpoint Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Redpoint Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$259K	Hold	4,191	–	–	0.04%	503
2022 Q2	$334K	Hold	4,191	–	–	0.04%	483
2022 Q1	$441K	Hold	4,191	–	–	0.04%	452
2021 Q4	$452K	Hold	4,191	–	–	0.04%	477
2021 Q3	$459K	Hold	4,191	–	–	0.04%	469
2021 Q2	$392K	Hold	4,191	–	–	0.03%	518
2021 Q1	$386K	Hold	4,191	–	–	0.03%	509
2020 Q4	$307K	Buy	+4,191	New	+$312K	0.03%	476

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Redpoint Investment Management's HZNP Position: Q3 2022 in Review

Redpoint Investment Management held its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) position steady in Q3 2022 at 4,191 shares worth $259K. The position accounts for 0.04% of the portfolio, ranked #503.

Redpoint Investment Management first reported a position in HZNP in Q4 2020 and has held it in 8 quarters since. The position peaked at $459K in Q3 2021. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

Redpoint Investment Management held 4,191 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $259K as of Q3 2022.
Redpoint Investment Management left its Horizon Therapeutics Public Limited Company Ordinary Shares share count unchanged in Q3 2022.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.04% of Redpoint Investment Management's portfolio in Q3 2022, its #503 holding.
Redpoint Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and has held it in 8 quarters since.
Redpoint Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $459K in Q3 2021.
530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.